Skip to content

Acceptance-Based Treatment for Prostate Cancer Distress

Pilot Study of an Acceptance and Commitment Therapy Workshop for Distress and Decision Making in Early Stage Prostate Cancer in Veterans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01594593
Enrollment
24
Registered
2012-05-09
Start date
2011-03-31
Completion date
2012-11-30
Last updated
2012-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Stage Prostate Cancer

Keywords

prostate cancer, behavioral, acceptance and commitment therapy, distress

Brief summary

Prostate cancer (PCa) is the most common type of cancer in men and the second leading cause of death in American men. Those diagnosed with localized prostate cancer encounter three sources of psychological distress: 1) diagnosis itself, 2) treatment decision making, and 3) the often life-altering side effects of treatment. In addition, patients who choose to undergo active surveillance which focuses on monitoring cancer in lieu of treatment, experience distress related to living with cancer. Acceptance and Commitment Therapy (ACT) is an established psychosocial intervention that has been used extensively for mental health treatment and has shown benefits for various chronic conditions. ACT is a behavioral intervention that focuses on tolerating distress and improving function. This pilot study is designed to test the feasibility of ACT for distress reduction and improved quality of life in patients recently diagnosed with early-stage, localized PCa.

Interventions

BEHAVIORALAcceptance and Commitment Therapy

group-based behavioral workshop to address cancer-related distress

Sponsors

Alliant International University
CollaboratorOTHER
University of California, San Diego
CollaboratorOTHER
Veterans Medical Research Foundation
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Localized prostate cancer in Stages I or II * Ability to give informed consent * Age 18 to 80 years old * Willingness to come in for a day long intervention

Exclusion criteria

* Acute psychosis * Suicidal ideation * Homicidal ideation * Active substance abuse * Dementia

Design outcomes

Primary

MeasureTime frameDescription
Number of dropouts6 monthsBecause this is a pilot study to determine feasibility, one of the primary outcomes is the number of participants who drop out of the active treatment arm.
Number of refusals6 monthsBecause this is a pilot study to determine feasibility, one of the primary outcomes is the number of participants who refuse the active treatment arm.

Secondary

MeasureTime frame
Hospital Anxiety and Depression Scalebaseline, post intervention, 2 weeks post intervention, 3 months post intervention
Memorial Anxiety Scale for Prostate Cancerbaseline, post intervention, 2 weeks post intervention, 3 months post intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026